Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin

Yanqing Liu,Xiaoli Zheng,Qinqin Yu,Hua Wang,Fuqing Tan,Qianying Zhu,Lingmin Yuan,Huidi Jiang,Lushan Yu,Su Zeng
DOI: https://doi.org/10.1126/scitranslmed.aaf3124
IF: 17.1
2016-07-20
Science Translational Medicine
Abstract:The expression of drug transporter OCT2 is suppressed in renal cell carcinoma, and targeting this pathway sensitizes the tumor to oxaliplatin.
cell biology,medicine, research & experimental
What problem does this paper attempt to address?